Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Colorectal Cancer Metastatic × Loperamide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 10 Diarrhea 4 Rectal Neoplasms 3 Sarcoma, Alveolar Soft Part 2 Ovarian Neoplasms 2 Vulvar Neoplasms 1 Vulvar Diseases 1 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Urogenital Neoplasms 1 Triple Negative Breast Neoplasms 1 Short Bowel Syndrome 1 Recurrence 1 Papillomavirus Infections 1 Neoplasms 1 Melanoma 1 Lung Neoplasms 1 Low Anterior Resection Syndrome 1 Gliosarcoma 1 Glioblastoma 1 Esophageal Squamous Cell Carcinoma 1 Endometrial Neoplasms 1 Colorectal Neoplasms 1 Colorectal Cancer Metastatic 1 Colonic Neoplasms 1 Colitis, Ulcerative 1 Colitis 1 Chondrosarcoma 1 Chemotherapy-related Diarrhea 1

Interventions

Bevacizumab 18 Capecitabine 15 Oxaliplatin 10 Cetuximab 10 Irinotecan 9 Fluorouracil 8 Panitumumab 6 Leucovorin 6 aflibercept 5 trifluridine tipiracil drug combination 3 sintilimab 3 regorafenib 3 Nivolumab 3 Vemurafenib 2 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 2 Ipilimumab 2 Drug Therapy 2 spartalizumab 1 raltitrexed 1 pembrolizumab 1 masitinib 1 irinotecan sucrosofate 1 folfirinox 1 camrelizumab 1 balstilimab 1 atezolizumab 1 anisodamine 1 XELOX 1 Tyrosine Kinase Inhibitors 1 Tomography, X-Ray Computed 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03705442 2018-10-15

Probat-tmcc-17

University Hospital Rijeka

Phase 2 Unknown

Gastrointestinal

Colorectal Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡